LPI (LP Information)' newest research report, the “DTP Vaccine Industry Forecast” looks at past sales and reviews total world DTP Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected DTP Vaccine sales for 2023 through 2029. With DTP Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DTP Vaccine industry.
This Insight Report provides a comprehensive analysis of the global DTP Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DTP Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global DTP Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DTP Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DTP Vaccine.
The global DTP Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for DTP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for DTP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for DTP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key DTP Vaccine players cover SANOFI PASTEUR, NOVARTIS, Vaxelis, GSK, Serum Institute of India, Johnson & Johnson, Merck Sharp & Dohme Corp, Seqirus and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of DTP Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Pertussis
Diphtheria
Tetanus
Segmentation by application
Hospital
Epidemic Prevention Station
Village Health Room
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SANOFI PASTEUR
NOVARTIS
Vaxelis
GSK
Serum Institute of India
Johnson & Johnson
Merck Sharp & Dohme Corp
Seqirus
Pfizer
Astrazeneca
astellas
Emergent BioSolutions Inc
WALVAX
Wuhan Institute of Biological Products Co.,Ltd.
Chengdu Institute of Biological Products Co.,Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global DTP Vaccine market?
What factors are driving DTP Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do DTP Vaccine market opportunities vary by end market size?
How does DTP Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global DTP Vaccine Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for DTP Vaccine by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for DTP Vaccine by Country/Region, 2018, 2022 & 2029 2.2 DTP Vaccine Segment by Type 2.2.1 Pertussis 2.2.2 Diphtheria 2.2.3 Tetanus 2.3 DTP Vaccine Sales by Type 2.3.1 Global DTP Vaccine Sales Market Share by Type (2018-2023) 2.3.2 Global DTP Vaccine Revenue and Market Share by Type (2018-2023) 2.3.3 Global DTP Vaccine Sale Price by Type (2018-2023) 2.4 DTP Vaccine Segment by Application 2.4.1 Hospital 2.4.2 Epidemic Prevention Station 2.4.3 Village Health Room 2.5 DTP Vaccine Sales by Application 2.5.1 Global DTP Vaccine Sale Market Share by Application (2018-2023) 2.5.2 Global DTP Vaccine Revenue and Market Share by Application (2018-2023) 2.5.3 Global DTP Vaccine Sale Price by Application (2018-2023) 3 Global DTP Vaccine by Company 3.1 Global DTP Vaccine Breakdown Data by Company 3.1.1 Global DTP Vaccine Annual Sales by Company (2018-2023) 3.1.2 Global DTP Vaccine Sales Market Share by Company (2018-2023) 3.2 Global DTP Vaccine Annual Revenue by Company (2018-2023) 3.2.1 Global DTP Vaccine Revenue by Company (2018-2023) 3.2.2 Global DTP Vaccine Revenue Market Share by Company (2018-2023) 3.3 Global DTP Vaccine Sale Price by Company 3.4 Key Manufacturers DTP Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers DTP Vaccine Product Location Distribution 3.4.2 Players DTP Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for DTP Vaccine by Geographic Region 4.1 World Historic DTP Vaccine Market Size by Geographic Region (2018-2023) 4.1.1 Global DTP Vaccine Annual Sales by Geographic Region (2018-2023) 4.1.2 Global DTP Vaccine Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic DTP Vaccine Market Size by Country/Region (2018-2023) 4.2.1 Global DTP Vaccine Annual Sales by Country/Region (2018-2023) 4.2.2 Global DTP Vaccine Annual Revenue by Country/Region (2018-2023) 4.3 Americas DTP Vaccine Sales Growth 4.4 APAC DTP Vaccine Sales Growth 4.5 Europe DTP Vaccine Sales Growth 4.6 Middle East & Africa DTP Vaccine Sales Growth 5 Americas 5.1 Americas DTP Vaccine Sales by Country 5.1.1 Americas DTP Vaccine Sales by Country (2018-2023) 5.1.2 Americas DTP Vaccine Revenue by Country (2018-2023) 5.2 Americas DTP Vaccine Sales by Type 5.3 Americas DTP Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC DTP Vaccine Sales by Region 6.1.1 APAC DTP Vaccine Sales by Region (2018-2023) 6.1.2 APAC DTP Vaccine Revenue by Region (2018-2023) 6.2 APAC DTP Vaccine Sales by Type 6.3 APAC DTP Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe DTP Vaccine by Country 7.1.1 Europe DTP Vaccine Sales by Country (2018-2023) 7.1.2 Europe DTP Vaccine Revenue by Country (2018-2023) 7.2 Europe DTP Vaccine Sales by Type 7.3 Europe DTP Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa DTP Vaccine by Country 8.1.1 Middle East & Africa DTP Vaccine Sales by Country (2018-2023) 8.1.2 Middle East & Africa DTP Vaccine Revenue by Country (2018-2023) 8.2 Middle East & Africa DTP Vaccine Sales by Type 8.3 Middle East & Africa DTP Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of DTP Vaccine 10.3 Manufacturing Process Analysis of DTP Vaccine 10.4 Industry Chain Structure of DTP Vaccine 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 DTP Vaccine Distributors 11.3 DTP Vaccine Customer 12 World Forecast Review for DTP Vaccine by Geographic Region 12.1 Global DTP Vaccine Market Size Forecast by Region 12.1.1 Global DTP Vaccine Forecast by Region (2024-2029) 12.1.2 Global DTP Vaccine Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global DTP Vaccine Forecast by Type 12.7 Global DTP Vaccine Forecast by Application 13 Key Players Analysis 13.1 SANOFI PASTEUR 13.1.1 SANOFI PASTEUR Company Information 13.1.2 SANOFI PASTEUR DTP Vaccine Product Portfolios and Specifications 13.1.3 SANOFI PASTEUR DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 SANOFI PASTEUR Main Business Overview 13.1.5 SANOFI PASTEUR Latest Developments 13.2 NOVARTIS 13.2.1 NOVARTIS Company Information 13.2.2 NOVARTIS DTP Vaccine Product Portfolios and Specifications 13.2.3 NOVARTIS DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 NOVARTIS Main Business Overview 13.2.5 NOVARTIS Latest Developments 13.3 Vaxelis 13.3.1 Vaxelis Company Information 13.3.2 Vaxelis DTP Vaccine Product Portfolios and Specifications 13.3.3 Vaxelis DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Vaxelis Main Business Overview 13.3.5 Vaxelis Latest Developments 13.4 GSK 13.4.1 GSK Company Information 13.4.2 GSK DTP Vaccine Product Portfolios and Specifications 13.4.3 GSK DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 GSK Main Business Overview 13.4.5 GSK Latest Developments 13.5 Serum Institute of India 13.5.1 Serum Institute of India Company Information 13.5.2 Serum Institute of India DTP Vaccine Product Portfolios and Specifications 13.5.3 Serum Institute of India DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Serum Institute of India Main Business Overview 13.5.5 Serum Institute of India Latest Developments 13.6 Johnson & Johnson 13.6.1 Johnson & Johnson Company Information 13.6.2 Johnson & Johnson DTP Vaccine Product Portfolios and Specifications 13.6.3 Johnson & Johnson DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Johnson & Johnson Main Business Overview 13.6.5 Johnson & Johnson Latest Developments 13.7 Merck Sharp & Dohme Corp 13.7.1 Merck Sharp & Dohme Corp Company Information 13.7.2 Merck Sharp & Dohme Corp DTP Vaccine Product Portfolios and Specifications 13.7.3 Merck Sharp & Dohme Corp DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Merck Sharp & Dohme Corp Main Business Overview 13.7.5 Merck Sharp & Dohme Corp Latest Developments 13.8 Seqirus 13.8.1 Seqirus Company Information 13.8.2 Seqirus DTP Vaccine Product Portfolios and Specifications 13.8.3 Seqirus DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Seqirus Main Business Overview 13.8.5 Seqirus Latest Developments 13.9 Pfizer 13.9.1 Pfizer Company Information 13.9.2 Pfizer DTP Vaccine Product Portfolios and Specifications 13.9.3 Pfizer DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Pfizer Main Business Overview 13.9.5 Pfizer Latest Developments 13.10 Astrazeneca 13.10.1 Astrazeneca Company Information 13.10.2 Astrazeneca DTP Vaccine Product Portfolios and Specifications 13.10.3 Astrazeneca DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Astrazeneca Main Business Overview 13.10.5 Astrazeneca Latest Developments 13.11 astellas 13.11.1 astellas Company Information 13.11.2 astellas DTP Vaccine Product Portfolios and Specifications 13.11.3 astellas DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 astellas Main Business Overview 13.11.5 astellas Latest Developments 13.12 Emergent BioSolutions Inc 13.12.1 Emergent BioSolutions Inc Company Information 13.12.2 Emergent BioSolutions Inc DTP Vaccine Product Portfolios and Specifications 13.12.3 Emergent BioSolutions Inc DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Emergent BioSolutions Inc Main Business Overview 13.12.5 Emergent BioSolutions Inc Latest Developments 13.13 WALVAX 13.13.1 WALVAX Company Information 13.13.2 WALVAX DTP Vaccine Product Portfolios and Specifications 13.13.3 WALVAX DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 WALVAX Main Business Overview 13.13.5 WALVAX Latest Developments 13.14 Wuhan Institute of Biological Products Co.,Ltd. 13.14.1 Wuhan Institute of Biological Products Co.,Ltd. Company Information 13.14.2 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Product Portfolios and Specifications 13.14.3 Wuhan Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Wuhan Institute of Biological Products Co.,Ltd. Main Business Overview 13.14.5 Wuhan Institute of Biological Products Co.,Ltd. Latest Developments 13.15 Chengdu Institute of Biological Products Co.,Ltd. 13.15.1 Chengdu Institute of Biological Products Co.,Ltd. Company Information 13.15.2 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Product Portfolios and Specifications 13.15.3 Chengdu Institute of Biological Products Co.,Ltd. DTP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Chengdu Institute of Biological Products Co.,Ltd. Main Business Overview 13.15.5 Chengdu Institute of Biological Products Co.,Ltd. Latest Developments 14 Research Findings and Conclusion